(
A) Gene targeting scheme to change the sequence coding for the exonuclease active site amino acid residues (
DIE) at the endogenous human Pol ε locus (POLE) to DNA coding for exonuclease-inactive residues (
AIA). Two regions (HA1 and HA2) of the POLE locus (
dotted lines) containing exons 7 and 8 and exons 9–11 (
black boxes), respectively, were amplified from HCT-116 cells and used as homology arms in rAAV construction. The rAAV created for gene targeting used a promoterless neomycin-resistance marker containing a splice acceptor site and introduced a novel SacI cleavage site into the POLE locus (
Rago et al., 2007). LoxP sites (
triangles) flanked the cassette, allowing for Cre-mediated cassette excision. Arrows denote PCR primers. Predicted sizes of SacI-digested fragments hybridizing to HA2-derived Southern blot probe are shown in italics. (
B) The indicated primer pairs (shown on the scheme in
A) were used to amplify the indicated region of genomic DNA from geneticin
r (cassette integration after viral transduction,
upper) and geneticin
s (after Cre-mediated excision,
lower) clones to verify construct integration at the genomic POLE locus and subsequent excision. (
C) Genomic DNA from parental HCT116 cells (POLEwt/wt) and cells where one copy of proofreading exonuclease was inactivated (POLEwt/exo-) was prepared and a region containing exon 9 was amplified by PCR and sequenced to verify gene targeting. Asterisks denote bases changed by site-directed mutagenesis.